Jan17Thu
Jan09Wed
[WATCH] Almac Group celebrates 50 years! Click HERE to start the video.
Jan08Tue
Galen Appoints Dr Dennise Broderick as Managing Director
Craigavon, N.I., 8 January 2019 – Galen Ltd, the Northern Ireland based pharmaceutical company, is delighted to announce the appointment of Dr Dennise Broderick as its new Managing Director and President. She will report to Alan Armstrong, CEO and Chairman, Almac Group, – the parent company of Galen Ltd.Together with Almac Group’s Board of Directors, Dennise is responsible for all aspects of the specialist pharmaceutical company’s operations, marketing and governance across its sites throughout Europe and the US.
Jan07Mon
This Friday, January 11th at 7:00 PM, a Month’s Mind Requiem Mass will be held in loving memory of our friend and member, Liam Hegarty. The mass will be held at Saints Simon and Jude in West Chester. All are welcome to share in the liturgy in remembrance of Liam.
Jan02Wed
Almac Group Launches Second Line for High Throughput GMP Peptide
Craigavon, N.I., 2 January 2019 – Almac Group, the global contract development and manufacturing organisation, is delighted to announce that they have brought online a second stream for High Throughput GMP Peptide manufacturing.
The High Throughput GMP Peptide facility, based in Edinburgh, Scotland, manufactures neoantigen derived peptides for use in the production of patient specific, individualised cancer vaccines.
